De Oro Devices’ NexStride To Help Freezing Gait Is Targeting Expansion To Other Diseases, Software Integration

De Oro Devices’ plans to add more indications for its portable device for freezing gait associated with Parkinson’s disease. In 2023, the company hopes to address multiple sclerosis, stroke and cerebral palsy, and add mobility-gait software.

Nextstride
• Source: Nextstride

With another $2.8m seed round padding its coffers, de Oro Devices CEO Sidney Collin wants to create more awareness for NexStride, a portable device to help people with Parkinson’s disease overcome “freezing gait” and expand into other disease states such as multiple sclerosis, stroke and cerebral palsy.

The seed financing, first announced in June, was led by True Wealth Ventures with participation from AARP, StartUp Health, Capital Factory, Wai Mohala Ventures, Kachuwa Impact Fund, Barton Investments, HealthTech...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Digital Technologies

More from Medtech Insight